ST. LOUIS, November 9, 2022 — CPS Solutions, LLC (CPS) and ANiGENT have agreed to work together in decreasing risks of drug diversion events at facilities and in applying new approaches to improve practice errors. 

“We are honored to work with CPS to combat drug diversion,” said ANiGENT CEO Virgilio “Jun” Fabella, Jr. “We have a mutual concern in protecting patients and healthcare workers and this collaboration will enable us to share our insights and solutions to CPS customers.”

CPS is a leading provider of pharmacy solutions to over 400 hospitals and facilities that serve to optimize patient care. For clients seeking an innovative approach to solving practice errors and reducing drug diversion risks, they can now look to ANiGENT to provide a solution.

ANiGENT’s comprehensive, patent-pending drug diversion prevention platform — MAAP Analytics® — is currently used by more than 80 healthcare facilities across the US. MAAP Analytics:

     • Predicts potential diversion or practice error behavior with near 100% accuracy 

     • Utilizes human intelligence to drive data quality and employs artificial intelligence (AI) to serve as the enabler, ensuring accuracy

       and minimizing false positives

     • Features an advanced risk rating algorithm

To learn more how MAAP Analytics can identify all drugs, all medications in all locations, contact 833-264-4368.